{"meshTags":["Animals","Antibodies, Monoclonal","Antibodies, Monoclonal, Humanized","Antineoplastic Agents","Biomarkers, Tumor","Breast Neoplasms","Female","Genes, erbB-2","Humans","Receptor, ErbB-2","Signal Transduction","Trastuzumab"],"meshMinor":["Animals","Antibodies, Monoclonal","Antibodies, Monoclonal, Humanized","Antineoplastic Agents","Biomarkers, Tumor","Breast Neoplasms","Female","Genes, erbB-2","Humans","Receptor, ErbB-2","Signal Transduction","Trastuzumab"],"genes":["HER2","neu"],"publicationTypes":["Journal Article","Research Support, Non-U.S. Gov\u0027t","Research Support, U.S. Gov\u0027t, P.H.S.","Review"],"title":"HER2/neu in the management of invasive breast cancer.","pubmedId":"11949754"}